Head of the Division

This division focuses on evaluation and treatment of benign hematological disorders in all age groups and malignant hematological disorders in patients aged 15 and above. Inpatient care is given  in a dedicated intensive chemotherapy unit and  general wards. High intensity chemotherapies like acute leukemia induction, consolidation etc are administered  in Intensive Chemotherapy unit, which are single occupancy  air-conditioned  rooms . Outpatient department caters to around 10000 patients in a year with around 2500 new case registrations. Day care chemotherapy is administered in a day chemo ward equipped with biosafety cabinets. 
This division also provides Hematopoietic stem cell transplantation for benign and malignant disorders in both adults and in children. Bone marrow transplantation unit of MCC established in 2013 is one among the two in Kerala under government sector and the first  in government sector to perform paediatric stem cell transplant and stem cell transplantation for benign hematologic disorders. It is a 4 bedded HEPA filtered state of the art BMT unit with attached operation theatre, dialysis unit, stem cell collection unit and stem cell lab. The unit has dedicated staff nurses trained in managing patients planned for and undergoing stem cell transplant. Till date(August 2022) MCC has performed 42 allogeneic and 130 autologous stem cell transplants. This includes matched sibling transplants, matched unrelated donor transplants and haploidentical transplants. Being a government centre, a large proportion of these treatments have been given with government funds ( Kerala social security mission ). 
Academic sessions are conducted every Wednesday and Thursday. Residents are assigned specific topics for presentation . They are trained to interpret the evidences and clinical trial datas through regular journal discussions. Faculty also has a regular academic schedule. CPC (clinico-pathologic correlation ) meetings happen on every 1st and 3rd wednesday for discussing cases with diagnostic dilemmas. Residents are actively engaged in these discussions.Mortality and morbidity meetings are conducted on regular basis in the department as well as in the institution. 
Transplant board meetings are conducted at least once a month, and if the situation demands more frequently. Planned transplant cases are discussed and decisions on transplant, risk assessment, conditioning regimen, type of transplant etc are deliberated in this meeting. 
Division of Clinical Haematology, Malabar Cancer Centre is member of Haematology cancer consortium, India and actively contributes to Haematology cancer registry and is an active participant in Virtual Tumor Board of National Cancer Grid (NCG), India. The division also participates in active research in the field of hematology including Clinical trials.